Miteva L, Stanilov N, Deliysky T, Mintchev N, Stanilova S
Department of Molecular Biology, Immunology and Genetics, Faculty of Medicine, Trakia University, Stara Zagora, Bulgaria.
Cancer Invest. 2009 Nov;27(9):924-31. doi: 10.3109/07357900902918486.
The present study investigates the association between IL12Bpro and +16974A/C in 3' -untranslated region (UTR) polymorphisms of IL12B and IL-12p40 serum level related to development of colorectal cancer (CRC). Our results showed similar distribution of both the investigated polymorphisms among CRC patients and healthy donors, which suggests that these polymorphisms in IL12B were not associated with the development of CRC. However, we found an increased IL-12p40 level in sera from patients compared to healthy donors and the highest level was observed in stage I compared to more advanced stages of CRC. These findings demonstrated that IL-12p40 serum level has an association with the progression of CRC.
本研究调查了白细胞介素12B(IL12B)基因启动子(IL12Bpro)及3'-非翻译区(UTR)中+16974A/C多态性与结直肠癌(CRC)发生发展相关的IL-12p40血清水平之间的关联。我们的结果显示,CRC患者和健康供体中所研究的这两种多态性分布相似,这表明IL12B中的这些多态性与CRC的发生无关。然而,我们发现,与健康供体相比,患者血清中的IL-12p40水平升高,并且在CRC的I期观察到的水平最高,而在更晚期阶段水平较低。这些发现表明,IL-12p40血清水平与CRC的进展相关。